Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-19
DOI
10.1038/s41374-022-00821-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of dysregulated PI3Kdelta signaling in human autoimmunity*
- (2022) Julia Bier et al. IMMUNOLOGICAL REVIEWS
- Recent Advances of PI3 Kinase Inhibitors: Structure Anticancer Activity Relationship Studies
- (2022) Vivek Asati et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling
- (2022) Eleonora Sementino et al. MOLECULAR CANCER RESEARCH
- p21-Activated Kinase 1 Promotes Breast Tumorigenesis via Phosphorylation and Activation of the Calcium/Calmodulin-Dependent Protein Kinase II
- (2022) Héctor I. Saldivar-Cerón et al. Frontiers in Cell and Developmental Biology
- PIK3CA Mutations in Diffuse Gliomas: An Update on Molecular Stratification, Prognosis, Recurrence, and Aggressiveness
- (2022) Cheila Brito et al. Clinical Medicine Insights-Oncology
- Nuclear upregulation of class I phosphoinositide 3-kinase p110β correlates with high 47S rRNA levels in cancer cells
- (2021) Fatemeh Mazloumi Gavgani et al. JOURNAL OF CELL SCIENCE
- Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
- (2021) Mayra Colardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation
- (2021) Hua‑fu Zhao et al. Cancer Cell International
- Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma
- (2021) Loretta J. Nastoupil et al. LEUKEMIA & LYMPHOMA
- PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth
- (2021) Nathalie Magne et al. CELLULAR ONCOLOGY
- A narrative review of research progress on drug therapies for glioblastoma multiforme
- (2021) Xiangjin Zheng et al. Annals of Translational Medicine
- PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma
- (2021) Husain Yar Khan et al. Cancers
- Emerging Roles of Pleckstrin-2 Beyond Cell Spreading
- (2021) Gengchen Wang et al. Frontiers in Cell and Developmental Biology
- TGFβ-induced expression of long noncoding lincRNA Platr18 controls breast cancer axonogenesis
- (2021) Simon Grelet et al. Life Science Alliance
- Publisher Correction: Progenitors from the central nervous system drive neurogenesis in cancer
- (2020) Philippe Mauffrey et al. NATURE
- Mesenchymal Transformation: The Rosetta Stone of Glioblastoma Pathogenesis and Therapy Resistance
- (2020) Zulfikar Azam et al. Advanced Science
- A map of tumor–host interactions in glioma at single-cell resolution
- (2020) Francesca Pia Caruso et al. GigaScience
- Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models
- (2020) Manojkumar R. Shukla et al. JOURNAL OF MEDICINAL CHEMISTRY
- The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives
- (2019) Zulfikar Azam et al. ACTA ONCOLOGICA
- PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer
- (2019) Jing-Song Chen et al. CANCER SCIENCE
- Metabolic derangements of skeletal muscle from a murine model of glioma cachexia
- (2019) Pengfei Cui et al. Skeletal Muscle
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2
- (2019) Caren Yu-Ju Wu et al. NEURO-ONCOLOGY
- Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells
- (2018) Yuwan Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages
- (2018) Evangelia Goulielmaki et al. Cell Death & Disease
- Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation
- (2018) Seiichi Okabe et al. ANNALS OF HEMATOLOGY
- Muscarinic m2 receptor-mediated actin polymerization via PI3 kinase γ and integrin-linked kinase in gastric smooth muscle
- (2018) Sunila Mahavadi et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- PIK3CB/p110β is a selective survival factor for glioblastoma
- (2017) Kevin J Pridham et al. NEURO-ONCOLOGY
- High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates
- (2017) Qiang Xue et al. Oncology Letters
- The effects of PI3K-mediated signalling on glioblastoma cell behaviour
- (2017) Julia Langhans et al. Oncogenesis
- The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma
- (2017) Kevin J. Pridham et al. Frontiers in Oncology
- Origin of the U87MG glioma cell line: Good news and bad news
- (2016) Marie Allen et al. Science Translational Medicine
- Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling
- (2016) Li-Fang He et al. Oncotarget
- Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?
- (2016) Kiruthikah Thillai et al. Oncotarget
- Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110
- (2013) A. Schulte et al. NEURO-ONCOLOGY
- The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
- (2011) Sze Ki Luk et al. EUROPEAN JOURNAL OF CANCER
- Elevated expression of Dickkopf-1 increases the sensitivity of human glioma cell line SHG44 to BCNU
- (2010) Youxin Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts
- (2010) Hongbo Chen et al. JOURNAL OF NEURO-ONCOLOGY
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started